Our current study demonstrates GRP78 is required for maintenance of “stemness” in pancreatic cancer and downregulating it interferes with cellular metabolism that contributes to survival advantage of treatment-refractory CSC population. The gene discussed is HSPA5; the disease is pancreatic neoplasm.